Serial Intravitreal Bevacizumab Injections Slow the Progression of Radiation Maculopathy Following Iodine-125 Plaque Radiotherapy.

CONCLUSIONS: Intravitreal bevacizumab injection was effective in stabilizing visual acuity in patients with radiation maculopathy. Patients benefited most from injections administered every 90 days or sooner. Fluorescein angiography can help identify patients who will respond favorably to treatment. PMID: 27053973 [PubMed]
Source: Open Ophthalmology Journal - Category: Opthalmology Tags: Open Ophthalmol J Source Type: research